MDS Treatment, Inqovi: Dr. Amer Zeidan Explains the Use of this Treament | Aplastic Anemia & MDS International Foundation

MDS Treatment, Inqovi: Dr. Amer Zeidan Explains the Use of this Treament

The recently-approved hypomethylating treatment, Inoqvi, is a daily oral version of two IV or subcutaneous medications.  Listen to Dr. Amer Zeidan of Yale Cancer Center explain which MDS patients could qualify, and what it means for their treatment at the link.